Nikolaos Bechrakis
Overview
Explore the profile of Nikolaos Bechrakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diarra Y, Brockmeyer C, Fischhuber K, Hulsenbeck I, Ting S, Reschke M, et al.
EJC Paediatr Oncol
. 2025 Mar;
1:None.
PMID: 40061040
Introduction: Advanced localized retinoblastoma can be cured by enucleation, but extraocular spread of retinoblastoma cells is associated with a high mortality. Risk-stratified adjuvant treatment with chemotherapy and radiotherapy has been...
2.
Guberina M, Stuschke M, Fluhs D, Jabbarli L, Kiefer T, Biewald E, et al.
Radiother Oncol
. 2025 Feb;
205:110775.
PMID: 39922315
Background: Dose-response relationships for optic neuropathy and optic nerve atrophy after brachytherapy for posterior uveal melanoma were poorly defined from previous studies. Here, the outcome differences were analyzed in dependence...
3.
Keyl J, Keyl P, Montavon G, Hosch R, Brehmer A, Mochmann L, et al.
Nat Cancer
. 2025 Jan;
6(2):307-322.
PMID: 39885364
Despite advances in precision oncology, clinical decision-making still relies on limited variables and expert knowledge. To address this limitation, we combined multimodal real-world data and explainable artificial intelligence (xAI) to...
4.
Alefeld E, Haase A, Van Meenen D, Budeus B, Drager O, Miroschnikov N, et al.
Cell Death Dis
. 2024 Dec;
15(12):905.
PMID: 39695086
Retinoblastoma (RB) is an intraocular tumor arising from retinal cone progenitor cells affecting young children. In the last couple of years, RB treatment evolved towards eye preserving therapies. Therefore, investigating...
5.
Feltgen N, Ach T, Bartz-Schmidt U, Bechrakis N, Eter N, Hattenbach L, et al.
Retina
. 2024 Sep;
44(12):e81-e83.
PMID: 39316834
No abstract available.
6.
Hoffmann C, Ringbaek T, Eckstein A, Deya W, Santiago A, Heintz M, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001692
Irradiation with electrons is the primary treatment regime for localized conjunctival low-grade lymphomas. However, radiation-induced cataracts are a major cause of treatment-related morbidity. This study investigates whether lens-sparing electron irradiation...
7.
Stohr M, Dekowski D, Bechrakis N, Oeverhaus M, Eckstein A
Ophthalmology
. 2023 Nov;
131(5):545-556.
PMID: 38000547
Purpose: Patients with incurable corneal diseases experience visual impairment (VI) despite having a healthy retina and optic pathway. Low-vision aids (LVAs) can optimize the use of remaining vision through magnification...
8.
Al-Ghazzawi K, Wessolly M, Dalbah S, Ketteler P, Kiefer T, Bechrakis N, et al.
Front Oncol
. 2023 Nov;
13:1144951.
PMID: 37965463
Retinoblastoma (RB) is the most common form of eye cancer experienced in childhood. Its aggressive malignancy is associated with excellent survival rates in high-income countries; however, the prognosis in third-world...
9.
Joussen A, Bechrakis N, Heimann H
Klin Monbl Augenheilkd
. 2023 Jul;
240(7):862.
PMID: 37467761
No abstract available.
10.
Oeverhaus M, Winkler L, Stahr K, Daser A, Bechrakis N, Stohr M, et al.
Front Endocrinol (Lausanne)
. 2023 Apr;
14:1160172.
PMID: 37082130
Purpose: Severity of Graves' orbitopathy (GO) shows wide individual differences. For optimal treatment, it is important to be able to predict the natural course of the disease as accurate as...